Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE
The ability of the bacterial pathogen Pseudomonas aeruginosa to cause both chronic and acute infections mainly relies on its capacity to finely modulate the expression of virulence factors through a complex network of regulatory circuits, including the pqs quorum sensing (QS) system. While in most Q...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e2d2cbeaef94dbdacc17226a46ffa91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7e2d2cbeaef94dbdacc17226a46ffa91 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7e2d2cbeaef94dbdacc17226a46ffa912021-11-17T14:21:58ZIdentification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE2150-55942150-560810.1080/21505594.2020.1770508https://doaj.org/article/7e2d2cbeaef94dbdacc17226a46ffa912020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1770508https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608The ability of the bacterial pathogen Pseudomonas aeruginosa to cause both chronic and acute infections mainly relies on its capacity to finely modulate the expression of virulence factors through a complex network of regulatory circuits, including the pqs quorum sensing (QS) system. While in most QS systems the signal molecule/receptor complexes act as global regulators that modulate the expression of QS-controlled genes, the main effector protein of the pqs system is PqsE. This protein is involved in the synthesis of the QS signal molecules 2-alkyl-4(1H)-quinolones (AQs), but it also modulates the expression of genes involved in virulence factors production and biofilm formation via AQ-independent pathway(s). P. aeruginosa pqsE mutants disclose attenuated virulence in plant and animal infection models, hence PqsE is considered a good target for the development of antivirulence drugs against P. aeruginosa. In this study, the negative regulation exerted by PqsE on its own transcription has been exploited to develop a screening system for the identification of PqsE inhibitors in a library of FDA-approved drugs. This led to the identification of nitrofurazone and erythromycin estolate, two antibiotic compounds that reduce the expression of PqsE-dependent virulence traits and biofilm formation in the model strain P. aeruginosa PAO1 at concentrations far below those affecting the bacterial growth rate. Notably, both drugs reduce the production of the PqsE-controlled virulence factor pyocyanin also in P. aeruginosa strains isolated from cystic fibrosis patients, and do not antagonize the activity of antibiotics commonly used to treat P. aeruginosa infection.Valerio BaldelliFrancesca D’AngeloViola PavoncelloErsilia Vita FiscarelliPaolo ViscaGiordano RampioniLivia LeoniTaylor & Francis Grouparticlepseudomonas aeruginosaantivirulence strategyquorum sensing inhibitionnitrofurazoneerythromycin estolatescreeningpqseInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 652-668 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
pseudomonas aeruginosa antivirulence strategy quorum sensing inhibition nitrofurazone erythromycin estolate screening pqse Infectious and parasitic diseases RC109-216 |
spellingShingle |
pseudomonas aeruginosa antivirulence strategy quorum sensing inhibition nitrofurazone erythromycin estolate screening pqse Infectious and parasitic diseases RC109-216 Valerio Baldelli Francesca D’Angelo Viola Pavoncello Ersilia Vita Fiscarelli Paolo Visca Giordano Rampioni Livia Leoni Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE |
description |
The ability of the bacterial pathogen Pseudomonas aeruginosa to cause both chronic and acute infections mainly relies on its capacity to finely modulate the expression of virulence factors through a complex network of regulatory circuits, including the pqs quorum sensing (QS) system. While in most QS systems the signal molecule/receptor complexes act as global regulators that modulate the expression of QS-controlled genes, the main effector protein of the pqs system is PqsE. This protein is involved in the synthesis of the QS signal molecules 2-alkyl-4(1H)-quinolones (AQs), but it also modulates the expression of genes involved in virulence factors production and biofilm formation via AQ-independent pathway(s). P. aeruginosa pqsE mutants disclose attenuated virulence in plant and animal infection models, hence PqsE is considered a good target for the development of antivirulence drugs against P. aeruginosa. In this study, the negative regulation exerted by PqsE on its own transcription has been exploited to develop a screening system for the identification of PqsE inhibitors in a library of FDA-approved drugs. This led to the identification of nitrofurazone and erythromycin estolate, two antibiotic compounds that reduce the expression of PqsE-dependent virulence traits and biofilm formation in the model strain P. aeruginosa PAO1 at concentrations far below those affecting the bacterial growth rate. Notably, both drugs reduce the production of the PqsE-controlled virulence factor pyocyanin also in P. aeruginosa strains isolated from cystic fibrosis patients, and do not antagonize the activity of antibiotics commonly used to treat P. aeruginosa infection. |
format |
article |
author |
Valerio Baldelli Francesca D’Angelo Viola Pavoncello Ersilia Vita Fiscarelli Paolo Visca Giordano Rampioni Livia Leoni |
author_facet |
Valerio Baldelli Francesca D’Angelo Viola Pavoncello Ersilia Vita Fiscarelli Paolo Visca Giordano Rampioni Livia Leoni |
author_sort |
Valerio Baldelli |
title |
Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE |
title_short |
Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE |
title_full |
Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE |
title_fullStr |
Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE |
title_full_unstemmed |
Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE |
title_sort |
identification of fda-approved antivirulence drugs targeting the pseudomonas aeruginosa quorum sensing effector protein pqse |
publisher |
Taylor & Francis Group |
publishDate |
2020 |
url |
https://doaj.org/article/7e2d2cbeaef94dbdacc17226a46ffa91 |
work_keys_str_mv |
AT valeriobaldelli identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse AT francescadangelo identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse AT violapavoncello identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse AT ersiliavitafiscarelli identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse AT paolovisca identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse AT giordanorampioni identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse AT livialeoni identificationoffdaapprovedantivirulencedrugstargetingthepseudomonasaeruginosaquorumsensingeffectorproteinpqse |
_version_ |
1718425492112015360 |